Why are drug prices so high? Investigating th...

Insurance is the hidden engine that keeps the economy churning, but climate change is making home insurance unaffordable for many people, says climate risk advisor Amy Barnes. She reveals why soaring premiums aren't just bad news for homeowners, but also a flashing red signal for ...  Show more

What happens when ordinary people win the lottery? Financial planner Matt Pitcher shares lessons from more than a decade of advising lotto winners, revealing how sudden wealth can unbalance life and spark consumerism — or create profound opportunities for meaning. This talk just ...  Show more

Between 2006 and 2016, the number of drug patents granted in the United States doubled -- but not because there was an explosion in invention or innovation. Drug companies have learned how to game the system, accumulating patents not for new medicines but for small changes to ...

Between 2006 and 2016, the number of drug patents granted in the United States doubled -- but not because there was an explosion in invention or innovation. Drug companies have learned how to game the system, accumulating patents not for new medicines but for small changes to ...

For decades, drugmakers have argued that patents are critical to bringing new drugs to the market. But in 2004, when a promising H.I.V. treatment emerged, Gilead Sciences decided to slow-walk its release to maximize profit on the company’s existing patents.

Rebecca Robbi ...

Back in the 1990s, Dr. Raghunath Mashelkar was in his office in New Delhi when he came across a puzzling story in the newspaper. Some university scientists in the U.S. had apparently filed a patent for using turmeric to help heal wounds. Mashelkar was shocked, because he knew tha ...  Show more